Scott Kern

Medicine & Life Sciences

1. Pancreatic Neoplasms 100%
2. Neoplasms 55%
3. Adenocarcinoma 51%
4. Mutation 39%
5. Pancreatic Carcinoma 38%
6. Genes 32%
7. Tumor Suppressor Genes 30%
8. Pancreas 24%
9. Loss of Heterozygosity 24%
10. Carcinoma 20%
11. Fanconi Anemia 19%
12. DNA 17%
13. Molecular Biology 16%
14. Carcinogenesis 14%
15. Thymidylate Synthase 14%
16. Colorectal Neoplasms 14%
17. Cell Line 13%
18. Gene Expression 12%
19. Transforming Growth Factors 12%
20. p16 Genes 11%
21. Germ-Line Mutation 11%
22. mesothelin 11%
23. ras Genes 10%
24. Neoplasm Genes 10%
25. Alleles 9%
26. Chromosomes 9%
27. Pancreatic Ducts 9%
28. Proteins 8%
29. Clone Cells 7%
30. Heterografts 7%
31. BRCA2 Gene 7%
32. p53 Genes 6%
33. Breast Neoplasms 6%
34. Familial Pancreatic carcinoma 6%
35. Tumor Biomarkers 6%
36. Exons 5%
37. Fluorouracil 5%
38. Sequence Tagged Sites 5%
39. Electrophoresis 5%
40. Biliary Tract Neoplasms 5%
41. Aneuploidy 5%
42. 5'-methylthioadenosine phosphorylase 5%
43. Carcinoma in Situ 5%
44. Growth Factor Receptors 5%
45. Genome 5%
46. Hypersensitivity 5%